Genetic sequence variants are associated with severity of lower urinary tract symptoms and prostate cancer susceptibility

Journal of Urology

Volumn 189, Issue 3, 2013, Pages 845-848

  Helfand, Brian T ^a   Hu, Qiaoyan ^b   Loeb, Stacy ^d   McVary, Kevin T ^c   Catalona, William J ^b  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

lower urinary tract symptoms; polymorphism, single nucleotide; prostate; prostatic hyperplasia; prostatic neoplasms

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; STEROID 5ALPHA REDUCTASE INHIBITOR;

ADULT; ALLELE; AMERICAN UROLOGICAL ASSOCIATION SYMPTOM INDEX; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CHROMOSOME 5P; CHROMOSOME 8Q; CHROMOSOME 9Q; CHROMOSOME XP; DISEASE SEVERITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATE HYPERTROPHY; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSURETHRAL RESECTION;

DNA, NEOPLASM; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; LOWER URINARY TRACT SYMPTOMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; UNITED STATES; URODYNAMICS;

EID: 84873708483     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.11.044     Document Type: Article

References (20)

1. A.W. Partin, W.F. Page, B.R. Lee Concordance rates for benign prostatic disease among twins suggest hereditary influence Urology 44 1994 646
2. J.D. Pearson, H.H. Lei, T.H. Beaty Familial aggregation of bothersome benign prostatic hyperplasia symptoms Urology 61 2003 781
3. S. Rohrmann, M.D. Fallin, W.F. Page Concordance rates and modifiable risk factors for lower urinary tract symptoms in twins Epidemiology 17 2006 419
4. M.G. Sanda, T.H. Beaty, R.E. Stutzman Genetic susceptibility of benign prostatic hyperplasia J Urol 152 1994 115
5. M.G. Sanda, C.B. Doehring, B. Binkowitz Clinical and biological characteristics of familial benign prostatic hyperplasia J Urol 157 1997 876
6. P. Lichtenstein, N.V. Holm, P.K. Verkasalo Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland N Engl J Med 343 2000 78
7. S.M. Edwards, R.A. Eeles Unravelling the genetics of prostate cancer Am J Med Genet C Semin Med Genet 129C 2004 65
8. T.A. Manolio Cohort studies and the genetics of complex disease Nat Genet 41 2009 5
9. Lindstrom S, Schumacher F, Siddiq A, et al. Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers-results from BPC3. PLoS One, 6: e17142.
10. S.L. Zheng, J. Sun, F. Wiklund Cumulative association of five genetic variants with prostate cancer N Engl J Med 358 2008 910
11. FitzGerald LM, Kwon EM, Conomos MP, et al. Genome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancer. Cancer Epidemiol Biomarkers Prev, 20: 1196.
12. J. Gudmundsson, P. Sulem, T. Rafnar Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer Nat Genet 40 2008 281
13. Nurminen R, Wahlfors T, Tammela TL, et al. Identification of an aggressive prostate cancer predisposing variant at 11q13. Int J Cancer, 129: 599.
14. Gudmundsson J, Besenbacher S, Sulem P, et al. Genetic correction of PSA values using sequence variants associated with PSA levels. Sci Transl Med, 2: 62ra92.
15. Le BV, Griffin CR, Loeb S, et al. [-2]Proenzyme prostate specific antigen is more accurate than total and free prostate specific antigen in differentiating prostate cancer from benign disease in a prospective prostate cancer screening study. J Urol, 183: 1355.
16. M.J. Barry, F.J. Fowler Jr, M.P. O'Leary The American Urological Association symptom index for benign prostatic hyperplasia. Measurement Committee of the American Urological Association J Urol 148 1992 1549
17. J. Gudmundsson, P. Sulem, D.F. Gudbjartsson Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility Nat Genet 41 2009 1122
18. J. Gudmundsson, P. Sulem, A. Manolescu Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24 Nat Genet 39 2007 631
19. N.J. Camp, J.M. Farnham, J. Wong Replication of the 10q11 and Xp11 prostate cancer risk variants: results from a Utah pedigree-based study Cancer Epidemiol Biomarkers Prev 18 2009 1290
20. Cooper PR, McGuire BB, Helfand BT, et al. Prostate cancer risk alleles and their associations with other malignancies. Urology, 78: 970 e15.